{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T20:48:01Z","timestamp":1782161281587,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Patients with overt cerebral ischemia are at risk for adverse events after hospital discharge. Sphingosine-1-phosphate is a potent lipid mediator produced and secreted by platelets, which is inhibited via acetylsalicylic acid (ASA). The associations of sphingosine-1-phosphate with biomarkers of platelet activation, i.e., thromboxane B\n                    <jats:sub>2<\/jats:sub>\n                    and soluble P-selectin, as well as with clinical outcome in ischemic stroke or transient ischemic attack patients\u2019 subgroups with and without ASA has not yet been investigated. The bioMARKers in STROKE (MARK-STROKE) cohort is a prospective, single-center, observational study including adult patients with a diagnosis of ischemic stroke or transient ischemic attack. Sphingosine-1-phosphate, thromboxane B\n                    <jats:sub>2<\/jats:sub>\n                    , and soluble P-selectin were measured by liquid chromatography-tandem mass spectrometry and ELISA, respectively, to investigate cross-sectional and outcome associations in ASA medication groups. Overall, we included 374 patients (median age 70 (IQR 58; 78) years; sex 242 (64.7%) males; ASA, yes 270 (72.2%)). During the first 365\u00a0days of follow-up, we recorded 79 adverse events (death, stroke, myocardial infarction, rehospitalization) in 274 patients with available follow-up. While no statistical differences in neurological and functional deficits were determined by sphingosine-1-phosphate, thromboxane B\n                    <jats:sub>2<\/jats:sub>\n                    , and soluble P-selectin in both ASA medication groups, patients without ASA intake and high soluble P-selectin had shorter event-free survival times (high soluble P-selectin 250 (95%CI 205; 296) days; low soluble P-selectin 331 (95%CI 304; 358) days;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.005). In addition, adjusted Cox-regression analysis revealed a higher hazard ratio (HR) for an adverse event during follow-up (HR\u2009=\u20093.22 (95%CI 1.41; 7.36);\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.005). Our findings may indicate the usability of soluble P-selectin in ASA-naive patients with ischemic stroke\/transient ischemic attack for risk stratification.\n                  <\/jats:p>","DOI":"10.1007\/s00210-025-04595-w","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:00:47Z","timestamp":1759917647000},"page":"3743-3750","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Associations of sphingosine-1-phosphate with soluble P-selectin and adverse clinical outcome in patients with cerebral ischemia with and without acetylsalicylic acid treatment"],"prefix":"10.1007","volume":"399","author":[{"given":"Nils-Ole","family":"Gloyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Moritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Schwieren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6tz","family":"Thomalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Daum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Magnus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"B\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-un","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard H.","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edzard","family":"Schwedhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"issue":"9","key":"4595_CR1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"V Aboyans","year":"2018","unstructured":"Aboyans V et al (2018) 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 39(9):763\u2013816","journal-title":"Eur Heart J"},{"issue":"25","key":"4595_CR2","doi-asserted-by":"publisher","first-page":"13835","DOI":"10.1073\/pnas.250475997","volume":"97","author":"P Andre","year":"2000","unstructured":"Andre P et al (2000) Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci U S A 97(25):13835\u201313840","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3\u20134","key":"4595_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/09537109876618","volume":"9","author":"PM Bath","year":"1998","unstructured":"Bath PM et al (1998) Von willebrand factor, P-selectin and fibrinogen levels in patients with acute ischaemic and haemorrhagic stroke, and their relationship with stroke sub-type and functional outcome. Platelets 9(3\u20134):155\u2013159","journal-title":"Platelets"},{"issue":"11","key":"4595_CR4","doi-asserted-by":"publisher","first-page":"4446","DOI":"10.1182\/blood.V92.11.4446","volume":"92","author":"G Berger","year":"1998","unstructured":"Berger G, Hartwell DW, Wagner DD (1998) P-selectin and platelet clearance. Blood 92(11):4446\u20134452","journal-title":"Blood"},{"issue":"2","key":"4595_CR5","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1055\/s-0038-1649788","volume":"74","author":"AD Blann","year":"1995","unstructured":"Blann AD et al (1995) von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thromb Haemost 74(2):626\u2013630","journal-title":"Thromb Haemost"},{"issue":"8","key":"4595_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/00001721-199611000-00008","volume":"7","author":"AD Blann","year":"1996","unstructured":"Blann AD (1996) Soluble p selectin in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease and its risk factors. Blood Coagul Fibrinolysis 7(8):789\u2013793","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"5","key":"4595_CR7","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1182\/blood.V73.5.1109.1109","volume":"73","author":"R Bonfanti","year":"1989","unstructured":"Bonfanti R et al (1989) PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. Blood 73(5):1109\u20131112","journal-title":"Blood"},{"issue":"7","key":"4595_CR8","doi-asserted-by":"publisher","first-page":"e468","DOI":"10.1161\/STR.0000000000000377","volume":"52","author":"DL Brown","year":"2021","unstructured":"Brown DL et al (2021) Benefits and risks of dual versus single antiplatelet therapy for secondary stroke prevention: a systematic review for the 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 52(7):e468\u2013e479","journal-title":"Stroke"},{"issue":"1","key":"4595_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0741-5214(03)00129-0","volume":"38","author":"K Cassar","year":"2003","unstructured":"Cassar K et al (2003) Platelet activation is increased in peripheral arterial disease. J Vasc Surg 38(1):99\u2013103","journal-title":"J Vasc Surg"},{"issue":"10","key":"4595_CR10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","volume":"23","author":"Collaborators GBDSRF","year":"2024","unstructured":"Collaborators GBDSRF (2024) Global, regional, and national burden of stroke and its risk factors, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 23(10):973\u20131003","journal-title":"Lancet Neurol"},{"issue":"25","key":"4595_CR11","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1056\/NEJMoa1804492","volume":"379","author":"Collaborators GBDLROS","year":"2018","unstructured":"Collaborators GBDLROS, GBD 2016 Lifetime Risk of Stroke Collaborators et al (2018) Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016. N Engl J Med 379(25):2429\u20132437","journal-title":"N Engl J Med"},{"issue":"1","key":"4595_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1161\/01.ATV.0000106320.40933.E5","volume":"24","author":"P da Costa Martins","year":"2004","unstructured":"da Costa Martins P et al (2004) Platelet-monocyte complexes support monocyte adhesion to endothelium by enhancing secondary tethering and cluster formation. Arterioscler Thromb Vasc Biol 24(1):193\u2013199","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"4595_CR13","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1055\/s-0040-1701205","volume":"4","author":"G Daum","year":"2020","unstructured":"Daum G et al (2020) Determinants of serum- and plasma sphingosine-1-phosphate concentrations in a healthy study group. TH Open 4(1):e12\u2013e19","journal-title":"TH Open"},{"issue":"11","key":"4595_CR14","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1161\/01.STR.28.11.2214","volume":"28","author":"CJ Frijns","year":"1997","unstructured":"Frijns CJ (1997) Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke 28(11):2214\u20132218","journal-title":"Stroke"},{"issue":"12","key":"4595_CR15","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1172\/JCI27196","volume":"115","author":"M Gawaz","year":"2005","unstructured":"Gawaz M, Langer H, May AE (2005) Platelets in inflammation and atherogenesis. J Clin Invest 115(12):3378\u20133384","journal-title":"J Clin Invest"},{"issue":"7","key":"4595_CR16","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1161\/STROKEAHA.120.029318","volume":"51","author":"G Hammond","year":"2020","unstructured":"Hammond G et al (2020) Urban-rural inequities in acute stroke care and in-hospital mortality. Stroke 51(7):2131\u20132138","journal-title":"Stroke"},{"issue":"7","key":"4595_CR17","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1161\/01.CIR.92.7.1693","volume":"92","author":"H Ikeda","year":"1995","unstructured":"Ikeda H et al (1995) Increased soluble form of P-selectin in patients with unstable angina. Circulation 92(7):1693\u20131696","journal-title":"Circulation"},{"issue":"38","key":"4595_CR18","doi-asserted-by":"publisher","first-page":"23708","DOI":"10.1016\/S0021-9258(17)31573-9","volume":"269","author":"N Ishiwata","year":"1994","unstructured":"Ishiwata N et al (1994) Alternatively spliced isoform of P-selectin is present in vivo as a soluble molecule. J Biol Chem 269(38):23708\u201323715","journal-title":"J Biol Chem"},{"issue":"23","key":"4595_CR19","doi-asserted-by":"publisher","first-page":"6015","DOI":"10.1182\/blood-2008-10-186650","volume":"113","author":"J Kisucka","year":"2009","unstructured":"Kisucka J et al (2009) Elevated levels of soluble P-selectin in mice alter blood-brain barrier function, exacerbate stroke, and promote atherosclerosis. Blood 113(23):6015\u20136022","journal-title":"Blood"},{"key":"4595_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00985","volume":"11","author":"J Liu","year":"2020","unstructured":"Liu J (2020) Serum sphingosine 1-phosphate (S1P): a novel diagnostic biomarker in early acute ischemic stroke. Front Neurol 11:985","journal-title":"Front Neurol"},{"issue":"1","key":"4595_CR21","doi-asserted-by":"publisher","first-page":"15308","DOI":"10.1038\/s41598-021-94052-4","volume":"11","author":"H Liu","year":"2021","unstructured":"Liu H et al (2021) Sphingosine-1-phosphate modulates PAR1-mediated human platelet activation in a concentration-dependent biphasic manner. Sci Rep 11(1):15308","journal-title":"Sci Rep"},{"issue":"11","key":"4595_CR22","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1161\/01.STR.0000034398.34938.20","volume":"33","author":"L Marquardt","year":"2002","unstructured":"Marquardt L et al (2002) Course of platelet activation markers after ischemic stroke. Stroke 33(11):2570\u20132574","journal-title":"Stroke"},{"issue":"1","key":"4595_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1172\/JCI114175","volume":"84","author":"RP McEver","year":"1989","unstructured":"McEver RP et al (1989) GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest 84(1):92\u201399","journal-title":"J Clin Invest"},{"issue":"6","key":"4595_CR24","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1160\/TH04-07-0433","volume":"92","author":"SK Nadar","year":"2004","unstructured":"Nadar SK, Lip GY, Blann AD (2004) Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke. The west Birmingham stroke project. Thromb Haemost 92(6):1342\u20131348","journal-title":"Thromb Haemost"},{"key":"4595_CR25","doi-asserted-by":"publisher","first-page":"6416","DOI":"10.1038\/ncomms7416","volume":"6","author":"C Nussbaum","year":"2015","unstructured":"Nussbaum C et al (2015) Sphingosine-1-phosphate receptor 3 promotes leukocyte rolling by mobilizing endothelial P-selectin. Nat Commun 6:6416","journal-title":"Nat Commun"},{"issue":"1","key":"4595_CR26","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1016\/S2468-2667(21)00230-9","volume":"7","author":"MO Owolabi","year":"2022","unstructured":"Owolabi MO et al (2022) Primary stroke prevention worldwide: translating evidence into action. Lancet Public Health 7(1):e74\u2013e85","journal-title":"Lancet Public Health"},{"issue":"2","key":"4595_CR27","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/j.ijcard.2013.10.050","volume":"170","author":"A Polzin","year":"2013","unstructured":"Polzin A et al (2013) Aspirin inhibits release of platelet-derived sphingosine-1-phosphate in acute myocardial infarction. Int J Cardiol 170(2):e23\u2013e24","journal-title":"Int J Cardiol"},{"issue":"11","key":"4595_CR28","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1161\/STROKEAHA.113.002881","volume":"44","author":"M Reeves","year":"2013","unstructured":"Reeves M et al (2013) Distribution of National Institutes of Health stroke scale in the Cincinnati\/Northern Kentucky stroke study. Stroke 44(11):3211\u20133213","journal-title":"Stroke"},{"issue":"4","key":"4595_CR29","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/01.CIR.103.4.491","volume":"103","author":"PM Ridker","year":"2001","unstructured":"Ridker PM, Buring JE, Rifai N (2001) Soluble P-selectin and the risk of future cardiovascular events. Circulation 103(4):491\u2013495","journal-title":"Circulation"},{"issue":"5","key":"4595_CR30","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/jamaneurol.2019.5061","volume":"77","author":"H Saber","year":"2020","unstructured":"Saber H, Saver JL (2020) Distributional validity and prognostic power of the National Institutes of Health Stroke Scale in US administrative claims data. JAMA Neurol 77(5):606\u2013612","journal-title":"JAMA Neurol"},{"issue":"12","key":"4595_CR31","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.1161\/STROKEAHA.120.033414","volume":"52","author":"E Schwedhelm","year":"2021","unstructured":"Schwedhelm E et al (2021a) Serum sphingosine-1-phosphate levels are associated with severity and outcome in patients with cerebral ischemia. Stroke 52(12):3901\u20133907","journal-title":"Stroke"},{"issue":"4","key":"4595_CR32","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00726-021-02969-x","volume":"53","author":"E Schwedhelm","year":"2021","unstructured":"Schwedhelm E et al (2021b) Trimethyllysine, vascular risk factors and outcome in acute ischemic stroke (MARK-STROKE). Amino Acids 53(4):555\u2013561","journal-title":"Amino Acids"},{"key":"4595_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2022.08.001","volume":"357","author":"E Schwedhelm","year":"2022","unstructured":"Schwedhelm E et al (2022) Effective high-density lipoprotein cholesterol is associated with carotid intima-media thickness and vascular events after acute ischemic stroke. Atherosclerosis 357:9\u201313","journal-title":"Atherosclerosis"},{"key":"4595_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/life13071590","author":"L Schwieren","year":"2023","unstructured":"Schwieren L et al (2023) Homoarginine associates with carotid intima-media thickness and atrial fibrillation and predicts adverse events after stroke. Life. https:\/\/doi.org\/10.3390\/life13071590","journal-title":"Life"},{"issue":"10","key":"4595_CR35","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1161\/STROKEAHA.114.005592","volume":"45","author":"HC Segal","year":"2014","unstructured":"Segal HC et al (2014) Population-based study of blood biomarkers in prediction of subacute recurrent stroke. Stroke 45(10):2912\u20132917","journal-title":"Stroke"},{"issue":"4","key":"4595_CR36","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0002-9149(97)00945-4","volume":"81","author":"H Shimomura","year":"1998","unstructured":"Shimomura H (1998) Serial changes in plasma levels of soluble P-selectin in patients with acute myocardial infarction. Am J Cardiol 81(4):397\u2013400","journal-title":"Am J Cardiol"},{"issue":"1","key":"4595_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1161\/01.HYP.0000022061.12297.2E","volume":"40","author":"CG Spencer","year":"2002","unstructured":"Spencer CG (2002) Von willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian cardiac outcomes trial (ASCOT). Hypertension 40(1):61\u201366","journal-title":"Hypertension"},{"issue":"3","key":"4595_CR38","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1083\/jcb.101.3.880","volume":"101","author":"PE Stenberg","year":"1985","unstructured":"Stenberg PE (1985) A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 101(3):880\u2013886","journal-title":"J Cell Biol"},{"issue":"8","key":"4595_CR39","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41582-019-0221-1","volume":"15","author":"G Stoll","year":"2019","unstructured":"Stoll G, Nieswandt B (2019) Thrombo-inflammation in acute ischaemic stroke - implications for treatment. Nat Rev Neurol 15(8):473\u2013481","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"4595_CR40","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1194\/jlr.M500268-JLR200","volume":"46","author":"M Tani","year":"2005","unstructured":"Tani M et al (2005) Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets. J Lipid Res 46(11):2458\u20132467","journal-title":"J Lipid Res"},{"issue":"11","key":"4595_CR41","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1111\/j.1538-7836.2004.00962.x","volume":"2","author":"J Thom","year":"2004","unstructured":"Thom J et al (2004) Measurement of soluble P-selectin and soluble CD40 ligand in serum and plasma. J Thromb Haemost 2(11):2067\u20132069","journal-title":"J Thromb Haemost"},{"issue":"22","key":"4595_CR42","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1056\/NEJM199005313222201","volume":"322","author":"MD Trip","year":"1990","unstructured":"Trip MD et al (1990) Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 322(22):1549\u20131554","journal-title":"N Engl J Med"},{"issue":"4","key":"4595_CR43","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/j.1538-7836.2011.04194.x","volume":"9","author":"T Ulrych","year":"2011","unstructured":"Ulrych T (2011) Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation. J Thromb Haemost 9(4):790\u2013798","journal-title":"J Thromb Haemost"},{"issue":"4","key":"4595_CR44","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1161\/CIRCRESAHA.115.306901","volume":"117","author":"N Urtz","year":"2015","unstructured":"Urtz N et al (2015) Sphingosine 1-phosphate produced by sphingosine kinase 2 intrinsically controls platelet aggregation in vitro and in vivo. Circ Res 117(4):376\u2013387","journal-title":"Circ Res"},{"issue":"3","key":"4595_CR45","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ijcard.2006.03.019","volume":"115","author":"J Wang","year":"2007","unstructured":"Wang J (2007) Elevated levels of platelet-monocyte aggregates and related circulating biomarkers in patients with acute coronary syndrome. Int J Cardiol 115(3):361\u2013365","journal-title":"Int J Cardiol"},{"issue":"10","key":"4595_CR46","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1161\/CIRCRESAHA.108.180273","volume":"103","author":"KJ Woollard","year":"2008","unstructured":"Woollard KJ (2008) Pathophysiological levels of soluble P-selectin mediate adhesion of leukocytes to the endothelium through Mac-1 activation. Circ Res 103(10):1128\u20131138","journal-title":"Circ Res"},{"issue":"1","key":"4595_CR47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1182\/blood.V86.1.193.bloodjournal861193","volume":"86","author":"Y Yatomi","year":"1995","unstructured":"Yatomi Y et al (1995) Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 86(1):193\u2013202","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1007\/s00210-026-05049-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000}}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04595-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04595-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04595-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:03:23Z","timestamp":1772780603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04595-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4595"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04595-w","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: There is a mistake in Fig. 1 of the original article. The graphs of figure 1 have been swapped wherein the p-value of the left part of the figure belongs to the right part and vice versa.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00210-026-05049-7","URL":"https:\/\/doi.org\/10.1007\/s00210-026-05049-7","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}